Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Cook Medical expands voluntary recall of angiographic catheters

Cook Medical announced that it has expanded its voluntary recall of angiographic catheters to include all lots of specific sizes. 

Thumbnail

TCT.15: Drug-coated balloon is superior to PTA in patients with peripheral artery disease

After two years of follow up, patients with peripheral artery disease who received a drug-coated balloon had significantly higher primary patency and a significantly lower rate of clinically driven target lesion revascularization compared with patients who received conventional percutaneous transluminal angioplasty (PTA).

Thumbnail

TCT.15: Researcher explains trial that led to FDA notification of potential TAVR, SAVR issues

The lead author of a recent trial that led to an FDA notification of potential issues with bioprosthetic aortic valves reiterated that the findings related to neurologic events were preliminary and inconclusive.

TCT.15: Everolimus-eluting stent is superior to paclitaxel-eluting stent in diabetic patients

A randomized trial found that patients with diabetes and coronary artery disease who underwent PCI and received paclitaxel-eluting stents had a significantly higher 1-year rate of the primary outcome of target-vessel failure compared with patients who received everolimus-eluting stents.

TCT.15: Thrombus aspiration does not improve long-term outcomes during PCI for STEMI

After a year of follow-up, patients with STEMI who received thrombus aspiration during PCI had similar results in the primary outcome of cardiovascular death, recurrent MI, cardiogenic shock or class IV heart failure compared with patients undergoing PCI alone, according to a prospective, randomized trial.

Thumbnail

TCT.15: Ranolazine does not improve outcomes in patients with incomplete revascularization after PCI

Providing ranolazine to patients with chronic angina and incomplete revascularization after undergoing PCI did not reduce the composite end point of ischemia-driven revascularization or hospitalization without revascularization, according to a multicenter, randomized, double-blind, placebo-controlled study.

TCT.15: Real world data with CoreValve TAVR system is similar to trial results

More than a year’s worth of real world data in more than 6,000 patients showed that all-cause mortality rates and stroke at 30 days with Medtronic’s CoreValve transcatheter aortic valve replacement (TAVR) system were comparable with findings in the pivotal trial that led to the device’s approval.

Thumbnail

TCT.15: Early results are promising for second-generation drug-eluting absorbable metal scaffold

Patients undergoing PCI who received a second-generation drug-eluting absorbable metal scaffold had favorable angiographic and clinical outcomes after six months, according to the first in-man study of the device.

Displaying 6665 - 6672 of 10742

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.